Literature DB >> 11543875

Identification and functional characterization of alpha(2)-adrenoceptor polymorphisms.

K M Small1, S B Liggett.   

Abstract

For each alpha(2)-adrenoceptor subtype (alpha(2A), alpha(2B) and alpha(2C)), sequence variations within the coding region of each gene have been identified in humans. These result in substitutions or deletions of amino acids in the third intracellular loops of each receptor. This article summarizes the genetics and molecular biology of alpha(2)-adrenoceptor polymorphisms, including the consequences of each polymorphism on receptor signaling, as determined in transfected cells. These effects include alterations in G-protein coupling, desensitization and G-protein receptor kinase-mediated phosphorylation. Studies so far provide the mechanistic basis for future studies to investigate genetic risk factors and pharmacogenetics in pathophysiological conditions linked to alpha(2)-adrenoceptor function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543875     DOI: 10.1016/s0165-6147(00)01758-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  11 in total

1.  Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene.

Authors:  Inna Belfer; Beata Buzas; Heather Hipp; Gabriel Phillips; Julie Taubman; Ilona Lorincz; Catherine Evans; Robert H Lipsky; Mary-Anne Enoch; Mitchell B Max; David Goldman
Journal:  J Hum Genet       Date:  2004-12-08       Impact factor: 3.172

2.  Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance.

Authors:  R Winker; A Barth; E Valic; R Maier; W Osterode; A Pilger; H W Rüdiger
Journal:  Int Arch Occup Environ Health       Date:  2005-02-18       Impact factor: 3.015

Review 3.  Genetic variation, β-blockers, and perioperative myocardial infarction.

Authors:  Peter Nagele; Stephen B Liggett
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

4.  The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers.

Authors:  Idoia Martín-Guerrero; Luis F Callado; Koldo Saitua; Guadalupe Rivero; Africa García-Orad; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2005-12-07       Impact factor: 4.530

5.  Lifestyle modifies the relationship between body composition and adrenergic receptor genetic polymorphisms, ADRB2, ADRB3 and ADRA2B: a secondary analysis of a randomized controlled trial of physical activity among postmenopausal women.

Authors:  Jennifer W Bea; Timothy G Lohman; Ellen C Cussler; Scott B Going; Patricia A Thompson
Journal:  Behav Genet       Date:  2010-04-18       Impact factor: 2.805

Review 6.  Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.

Authors:  Jörn Lötsch; Carsten Skarke; Jürgen Liefhold; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  The alpha2C-adrenoceptor deletion322-325 variant and cold-induced vasoconstriction.

Authors:  Eitan A Friedman; Paul A Harris; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Clin Auton Res       Date:  2009-05-15       Impact factor: 4.435

Review 8.  From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.

Authors:  Alessandro Serretti; Paola Artioli
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

9.  Common α2A and α2C adrenergic receptor polymorphisms do not affect plasma membrane trafficking.

Authors:  Carl M Hurt; Matt W Sorensen; Timothy Angelotti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-19       Impact factor: 3.000

10.  Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial.

Authors:  Even Fagermoen; Dag Sulheim; Anette Winger; Anders M Andersen; Johannes Gjerstad; Kristin Godang; Peter C Rowe; J Philip Saul; Eva Skovlund; Vegard Bruun Wyller
Journal:  BMC Pediatr       Date:  2015-09-10       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.